Kawasaki S, Umekita N, Beppu T, Wada T, Sugiyama Y, Iga T, Hanano M
Biochem Pharmacol. 1984 Oct 15;33(20):3219-24. doi: 10.1016/0006-2952(84)90080-7.
The pharmacokinetics of chenodeoxycholic acid (CDCA) in hepatic dysfunction were evaluated by analyzing the plasma disappearance curves after simultaneous administration of [3H]- and [14C]-CDCA through the femoral and portal veins, respectively, in dogs chronically intoxicated with dimethylnitrosamine (DMN). The plasma concentration-time curve of intravenously administered [3H]-CDCA was best fitted to a three-exponential equation, while that of intraportally administered [14C]-CDCA was fitted to either a two- or a three-exponential equation. In the DMN-intoxicated dogs, significant decreases were observed in total body plasma clearance (CLp), hepatic extraction ratio (EH) and apparent intrinsic clearance (CLint) compared to those of the untreated (control) dogs. The hepatic blood flow (QH), calculated from CLp, CLint and blood-to-plasma concentration ratio (RB) according to the equation reported by Wilkinson and Shand [Clin. Pharmac. Ther. 18, 377 (1975)], was reduced to approximately 70% in the DMN-intoxicated dogs compared to the control dogs. The bindings of CDCA to plasma and liver cytosol fraction were determined by equilibrium dialysis; no significant difference was observed in the unbound fraction between the DMN-treated and control dogs. By comparing both pharmacokinetic parameters obtained from intravenous and intraportal administration, the usefulness of the oral bile acid tolerance test was examined. From these findings, it was suggested that the decrease in the CLp of the DMN-intoxicated dogs was due to both the decrease in QH and that in CLint, and that the decrease in CLint may be due not to an alteration of plasma or cytosol binding but to that of a carrier-mediated transport system. It is also suggested that the measurement of fasting plasma bile acid concentration or the oral bile acid tolerance test is more sensitive for the detection of hepatic dysfunction than the intravenous bile acid tolerance test.
通过分别经股静脉和门静脉同时给予[3H]-和[14C]-鹅去氧胆酸(CDCA)后分析血浆消除曲线,对慢性二甲基亚硝胺(DMN)中毒犬肝功能不全时CDCA的药代动力学进行了评估。静脉注射[3H]-CDCA的血浆浓度-时间曲线最适合用三指数方程拟合,而经门静脉注射[14C]-CDCA的血浆浓度-时间曲线适合用二指数或三指数方程拟合。与未处理(对照)犬相比,DMN中毒犬的全身血浆清除率(CLp)、肝提取率(EH)和表观内在清除率(CLint)均显著降低。根据Wilkinson和Shand [临床药理学与治疗学18, 377 (1975)]报道的方程,由CLp、CLint和血药浓度比(RB)计算得出的肝血流量(QH),与对照犬相比,DMN中毒犬降低至约70%。通过平衡透析法测定了CDCA与血浆和肝细胞溶质部分的结合情况;DMN处理犬和对照犬的未结合部分未观察到显著差异。通过比较静脉注射和门静脉注射获得的药代动力学参数,检验了口服胆汁酸耐量试验的有效性。从这些结果表明,DMN中毒犬CLp的降低是由于QH和CLint的降低,且CLint的降低可能不是由于血浆或细胞溶质结合的改变,而是由于载体介导转运系统的改变。还表明,空腹血浆胆汁酸浓度的测定或口服胆汁酸耐量试验对肝功能不全的检测比静脉胆汁酸耐量试验更敏感。